The latest action by industry on COVID-19

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Z_Wei)
(Image: Getty/Z_Wei)

Related tags: COVID-19, Coronavirus, Supply chain, regulatory

A rundown of the latest updates emerging from industry in response to the developing coronavirus pandemic.

With the situation changing each day, we provide an update on the significant recent actions that have emerged from pharmaceutical companies and regulatory agencies to combat the novel coronavirus.

Protecting the supply chain

Regulatory reaction

Industry response

Potential treatments

Industry events

Related news

Show more

Related products

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us


View more